IBDEI1UW ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32678,1,3,0)
 ;;=3^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,32678,1,4,0)
 ;;=4^D47.3
 ;;^UTILITY(U,$J,358.3,32678,2)
 ;;=^5002258
 ;;^UTILITY(U,$J,358.3,32679,0)
 ;;=C82.09^^182^1992^59
 ;;^UTILITY(U,$J,358.3,32679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32679,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32679,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,32679,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,32680,0)
 ;;=C82.00^^182^1992^60
 ;;^UTILITY(U,$J,358.3,32680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32680,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,32680,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,32680,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,32681,0)
 ;;=C82.19^^182^1992^61
 ;;^UTILITY(U,$J,358.3,32681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32681,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32681,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,32681,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,32682,0)
 ;;=C82.10^^182^1992^62
 ;;^UTILITY(U,$J,358.3,32682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32682,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,32682,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,32682,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,32683,0)
 ;;=C82.29^^182^1992^63
 ;;^UTILITY(U,$J,358.3,32683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32683,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32683,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,32683,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,32684,0)
 ;;=C82.20^^182^1992^64
 ;;^UTILITY(U,$J,358.3,32684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32684,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Unspec Site
 ;;^UTILITY(U,$J,358.3,32684,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,32684,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,32685,0)
 ;;=C82.39^^182^1992^65
 ;;^UTILITY(U,$J,358.3,32685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32685,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32685,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,32685,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,32686,0)
 ;;=C82.30^^182^1992^66
 ;;^UTILITY(U,$J,358.3,32686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32686,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,32686,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,32686,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,32687,0)
 ;;=C82.49^^182^1992^67
 ;;^UTILITY(U,$J,358.3,32687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32687,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32687,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,32687,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,32688,0)
 ;;=C82.40^^182^1992^68
 ;;^UTILITY(U,$J,358.3,32688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32688,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,32688,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,32688,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,32689,0)
 ;;=C82.99^^182^1992^69
 ;;^UTILITY(U,$J,358.3,32689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32689,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32689,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,32689,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,32690,0)
 ;;=C82.90^^182^1992^70
 ;;^UTILITY(U,$J,358.3,32690,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1UW
